vTv Therapeutics Inc.
VTVT
$25.24
$1.747.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.21% | 3.08% | 9.35% | 8.83% | 14.92% |
| Total Depreciation and Amortization | -60.00% | -37.78% | -15.56% | -1.11% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.05% | -4,328.00% | 7.19% | 54.87% | 42.76% |
| Change in Net Operating Assets | 234.08% | 16.53% | -775.92% | -223.76% | -228.63% |
| Cash from Operations | 10.97% | -0.98% | -11.34% | -32.63% | -1.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 86.47% | 100.00% | 100.00% | 68.11% | 27.23% |
| Issuance of Common Stock | 46.76% | -95.09% | -95.11% | 338.89% | 229.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 48.61% | -95.19% | -95.11% | 338.50% | 228.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.80% | -159.54% | -163.29% | 1,118.66% | 569.41% |